AKT1 and neoplasm: Owing to the high expression of FAM83B resulted in intrinsic or selective drug resistance of tumor cells to genotoxicity or targeted therapy, the development of new therapies specific to FAM83 proteins may inhibit MAPK and PI3K/AKT signaling and the further expansion of drug-resistant tumor cells.